| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |